Solas BioVentures

Stimdia Medical develops a non-invasive lung pacing device that reduces the time required to get a patient off a ventilator, resulting in significant cost savings.

Pathware is on a mission to fundamentally improve healthcare by bringing computational microscopy and AI to the Point-of-Care in order to help pathologists and proceduralists accurately diagnose and treat diseases earlier and more precisely, ultimately saving lives globally.

CryOSA is a medical device company developing novel treatments for obstructive sleep apnea.

Francis Medical is a medical technology company developing therapeutic solutions to treat prostate, kidney, and bladder cancer. Francis Medical is developing a device for treating prostate cancer, the second most common cancer in American men, using a new platform to treat endourological cancers, water vapor technology. The thermal energy stored in sterile water vapor is used to treat cancerous tissue via a simple transurethral procedure, potentially minimizing life-altering side effects.

InterShunt designs and develops a catheter-based minimally-invasive procedure to provide relief for millions suffering from heart failure. It believes that left atrial decompression holds the key to reducing symptoms for those who suffer. It also believes that they can do this using a simple catheter procedure. Most importantly, they believe they can do this without the use of an implant. It was founded in 2015 and is headquartered in St Louis, Missouri.

Knopp Biosciences is a drug discovery and development company that focuses on delivering breakthrough treatments in neurological disorders through innovation, experience, and partnership. The company targets diseases imposing high costs on the healthcare system, with patient populations clearly identifiable using validated biomarkers or genetic testing. The company's goal is to accelerate and advance treatment, change the course of diseases, and improve the lives of the patients and their families. Knopp Biosciences was founded in 2004 and is headquartered in Pittsburgh, Pennsylvania.

BioStable is a cardiovascular device company that develops innovative new products for the treatment of cardiovascular diseases. The company is led by an experienced group of industry executives with expertise in rapid and effective medical device development. The organization incorporates core strengths in all areas of product development including quality systems, design, engineering, prototyping and pilot production, in-vitro and in-vivo testing, manufacturing, global regulatory relationships, clinical product validation, market launch, and distribution. BioStable provides a competitive edge by minimizing time to market for cost-effective medical devices that deliver improved clinical outcomes. The company focused on developing and commercializing proprietary valve repair technologies that provide an alternative to valve replacement for patients with aortic valve disease. BioStable was founded in

AEGEA Medical is pioneering the application of its Adaptive Vapor Ablation technology to deliver therapies that provide high quality patient outcomes to a wider range of patients. AEGEA’s FDA approved water vapor technology enables the delivery of a safe and effective endometrial ablation for the treatment of menorrhagia in a simple, office-based procedure that takes only minutes. With a vision to expand safe and effective treatment options to more patients, and provide physicians with the confidence and convenience necessary to perform office-based procedures, AEGEA is inspiring new approaches to women’s healthcare. Founded in 2008, AEGEA Medical is located in in Menlo Park, California.

AEGEA Medical is pioneering the application of its Adaptive Vapor Ablation technology to deliver therapies that provide high quality patient outcomes to a wider range of patients. AEGEA’s FDA approved water vapor technology enables the delivery of a safe and effective endometrial ablation for the treatment of menorrhagia in a simple, office-based procedure that takes only minutes. With a vision to expand safe and effective treatment options to more patients, and provide physicians with the confidence and convenience necessary to perform office-based procedures, AEGEA is inspiring new approaches to women’s healthcare. Founded in 2008, AEGEA Medical is located in in Menlo Park, California.

ATFX stands out as a premier Forex CFD broker, boasting a diverse range of over 300 CFD products, including forex currency pairs, indices, commodities like precious metals & crude oil, stocks, and other popular financial instruments. With a global footprint encompassing 21 offices across Europe, South America, Middle East, Asia, Australia, and South Africa, ATFX offers a comprehensive trading experience. The company's stellar reputation is underscored by its receipt of more than 80 prestigious international awards, recognizing excellence in online trading, customer service, and corporate social responsibility. Noteworthy accolades include 'Best Fintech Forex Broker', 'Global Forex Broker of the Year', and 'Best Forex Trading Experience'. ATFX's consistent performance is evident in its ranking among the Top 5 for Retail FX/ Other Volumes by MT4/ MT5 Usage in the Intelligence Report by Finance Magnates. Additionally, the company was honored as one of the 'Top 10 Hot Brands of the year 2021' by The CEO Views.

PreTel develops and offers fetal monitoring systems that improve both maternal and pediatric outcomes in the labor and delivery departments. The company offers uterine electromyography (uEMG) monitoring and area sensor solutions that solve the inability of accurately identifying true versus false labor with fetal monitoring, leading to unnecessary invasive monitoring, c-section deliveries, and expensive neonatal intensive care nursery stays. PreTel is based in Ontario, Canada.

Our expertise is drug development. Whether we are developing a reformulated product, a new chemical entity, or a biologic, the team at Arrivo BioVentures has expertise in identifying regulatory strategies to expedite the path to approval and the efficient implementation of the clinical programs themselves. We coordinate with the FDA (and other regulatory bodies) early and often to gain agreement on the development programs for our products, minimizing surprises and speeding implementation.

ATFX stands out as a premier Forex CFD broker, boasting a diverse range of over 300 CFD products, including forex currency pairs, indices, commodities like precious metals & crude oil, stocks, and other popular financial instruments. With a global footprint encompassing 21 offices across Europe, South America, Middle East, Asia, Australia, and South Africa, ATFX offers a comprehensive trading experience. The company's stellar reputation is underscored by its receipt of more than 80 prestigious international awards, recognizing excellence in online trading, customer service, and corporate social responsibility. Noteworthy accolades include 'Best Fintech Forex Broker', 'Global Forex Broker of the Year', and 'Best Forex Trading Experience'. ATFX's consistent performance is evident in its ranking among the Top 5 for Retail FX/ Other Volumes by MT4/ MT5 Usage in the Intelligence Report by Finance Magnates. Additionally, the company was honored as one of the 'Top 10 Hot Brands of the year 2021' by The CEO Views.

PreTel develops and offers fetal monitoring systems that improve both maternal and pediatric outcomes in the labor and delivery departments. The company offers uterine electromyography (uEMG) monitoring and area sensor solutions that solve the inability of accurately identifying true versus false labor with fetal monitoring, leading to unnecessary invasive monitoring, c-section deliveries, and expensive neonatal intensive care nursery stays. PreTel is based in Ontario, Canada.

AEGEA Medical is pioneering the application of its Adaptive Vapor Ablation technology to deliver therapies that provide high quality patient outcomes to a wider range of patients. AEGEA’s FDA approved water vapor technology enables the delivery of a safe and effective endometrial ablation for the treatment of menorrhagia in a simple, office-based procedure that takes only minutes. With a vision to expand safe and effective treatment options to more patients, and provide physicians with the confidence and convenience necessary to perform office-based procedures, AEGEA is inspiring new approaches to women’s healthcare. Founded in 2008, AEGEA Medical is located in in Menlo Park, California.